Introduction: Conclusive molecular genetic diagnoses in inherited retinal diseases remains a major challenge due to the large number of variants of uncertain significance (VUS) identified in genetic testing. Here, we determined the genotypic and phenotypic spectrum of ABCA4 gene variants in a cohort of Canadian inherited retinal dystrophy subjects. Methods: This retrospective study evaluated 64 subjects with an inherited retinal dystrophy diagnosis with variants in the ABCA4 gene. Pathogenicity of variants was assessed by comparison to genetic databases and in silico modelling. ABCA4 variants classified as VUS were further evaluated using a cryo-electron structural model of the ABCA4 protein to predict impact on protein function and were also assessed for evolutionary conservation. Results: Conclusive disease-causing biallelic ABCA4 variants were detected in 52 subjects with either Stargardt’s disease, cone-rod dystrophy, macular dystrophy, or pattern dystrophy. A further 14 variants were novel comprising 1 nonsense, 1 frameshift, 3 splicing, and 9 missense variants. Based on in silico modelling, protein modelling and evolutionary conservation from human to zebrafish, we re-classified 5 of these as pathogenic and a further 3 as likely pathogenic. We also added to the ABCA4 phenotypic spectrum seen with four known pathogenic variants (c.2161-2A>G; Leu296Cysfs*4; Arg1640Gln; and Pro1380Leu). Conclusions: This study expands the genotypic and phenotypic spectrum of ABCA4 disease-associated variants. By panel-based genetic testing, we identified 14 novel ABCA4 variants of which 8 were determined to be disease-causing or likely disease-causing. These methodologies could circumvent somewhat the need for labour intensive in vitro and in vivo assessments of novel ABCA4 variants.

1.
Allikmets
R
,
Singh
N
,
Sun
H
,
Shroyer
NF
,
Hutchinson
A
,
Chidambaram
A
, et al
.
A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy
.
Nat Genet
.
1997
;
15
(
3
):
236
46
.
2.
Westeneng-van Haaften
SC
,
Boon
CJ
,
Cremers
FP
,
Hoefsloot
LH
,
den Hollander
AI
,
Hoyng
CB
.
Clinical and genetic characteristics of late-onset Stargardt's disease
.
Ophthalmology
.
2012
;
119
(
6
):
1199
210
.
3.
Duncker
T
,
Tsang
SH
,
Lee
W
,
Zernant
J
,
Allikmets
R
,
Delori
FC
, et al
.
Quantitative fundus autofluorescence distinguishes ABCA4-associated and non-ABCA4-associated bull’s-eye maculopathy
.
Ophthalmology
.
2015
;
122
(
2
):
345
55
.
4.
Simonelli
F
,
Testa
F
,
Zernant
J
,
Nesti
A
,
Rossi
S
,
Rinaldi
E
, et al
.
Association of a homozygous nonsense mutation in the ABCA4 (ABCR) gene with cone-rod dystrophy phenotype in an Italian family
.
Ophthalmic Res
.
2004
;
36
(
2
):
82
8
.
5.
Tanaka
K
,
Lee
W
,
Zernant
J
,
Schuerch
K
,
Ciccone
L
,
Tsang
SH
, et al
.
The rapid-onset chorioretinopathy phenotype of ABCA4 disease
.
Ophthalmology
.
2018
;
125
(
1
):
89
99
.
6.
Martínez-Mir
A
,
Paloma
E
,
Allikmets
R
,
Ayuso
C
,
Del Rio
T
,
Dean
M
, et al
.
Retinitis pigmentosa caused by a homozygous mutation in the Stargardt disease gene ABCR
.
Nat Genet
.
1998
;
18
(
1
):
11
2
.
7.
Allikmets
R
,
Shroyer
NF
,
Singh
N
,
Seddon
JM
,
Lewis
RA
,
Bernstein
PS
, et al
.
Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration
.
Science
.
1997
;
277
(
5333
):
1805
7
.
8.
Molday
RS
,
Garces
FA
,
Scortecci
JF
,
Molday
LL
.
Structure and function of ABCA4 and its role in the visual cycle and Stargardt macular degeneration
.
Prog Retin Eye Res
.
2022
;
89
:
101036
.
9.
McBee
JK
,
Palczewski
K
,
Baehr
W
,
Pepperberg
DR
.
Confronting complexity: the interlink of phototransduction and retinoid metabolism in the vertebrate retina
.
Prog Retin Eye Res
.
2001
;
20
(
4
):
469
529
.
10.
Rattner
A
,
Smallwood
PM
,
Nathans
J
.
Identification and characterization of all-trans-retinol dehydrogenase from photoreceptor outer segments, the visual cycle enzyme that reduces all-trans-retinal to all-trans-retinol
.
J Biol Chem
.
2000
;
275
(
15
):
11034
43
.
11.
Beharry
S
,
Zhong
M
,
Molday
RS
.
N-retinylidene-phosphatidylethanolamine is the preferred retinoid substrate for the photoreceptor-specific ABC transporter ABCA4 (ABCR)
.
J Biol Chem
.
2004
;
279
(
52
):
53972
9
.
12.
Quazi
F
,
Lenevich
S
,
Molday
RS
.
ABCA4 is an N-retinylidene phosphatidylethanolamine and phosphatidylethanolamine importer
.
Nat Commun
.
2012
;
3
:
925
.
13.
Tsybovsky
Y
,
Molday
RS
,
Palczewski
K
.
The ATP-binding cassette transporter ABCA4: structural and functional properties and role in retinal disease
.
Adv Exp Med Biol
.
2010
;
703
:
105
25
.
14.
Molday
RS
,
Zhang
K
.
Defective lipid transport and biosynthesis in recessive and dominant Stargardt macular degeneration
.
Prog Lipid Res
.
2010
;
49
(
4
):
476
92
.
15.
Ben-Shabat
S
,
Parish
CA
,
Vollmer
HR
,
Itagaki
Y
,
Fishkin
N
,
Nakanishi
K
, et al
.
Biosynthetic studies of A2E, a major fluorophore of retinal pigment epithelial lipofuscin
.
J Biol Chem
.
2002
;
277
(
9
):
7183
90
.
16.
Sparrow
JR
,
Boulton
M
.
RPE lipofuscin and its role in retinal pathobiology
.
Exp Eye Res
.
2005
;
80
(
5
):
595
606
.
17.
Schachat
AP
,
Sarraf
D
,
Freund
KB
. In:
Sadda
SR
, In-chief editor., eds.
Ryan’s Retina
,
2
.
London
:
Elsevier
;
2023
. p.
879
1052
.
18.
Richards
S
,
Aziz
N
,
Bale
S
,
Bick
D
,
Das
S
,
Gastier-Foster
J
, et al
.
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
.
Genet Med
.
2015
;
17
(
5
):
405
24
.
19.
Scortecci
JF
,
Molday
LL
,
Curtis
SB
,
Garces
FA
,
Panwar
P
,
Van Petegem
F
, et al
.
Cryo-EM structures of the ABCA4 importer reveal mechanisms underlying substrate binding and Stargardt disease
.
Nat Commun
.
2021
;
12
(
1
):
5902
.
20.
Curtis
SB
,
Molday
LL
,
Garces
FA
,
Molday
RS
.
Functional analysis and classification of homozygous and hypomorphic ABCA4 variants associated with Stargardt macular degeneration
.
Hum Mutat
.
2020
;
41
(
11
):
1944
56
.
21.
Garces
FA
,
Scortecci
JF
,
Molday
RS
.
Functional characterization of ABCA4 missense variants linked to Stargardt macular degeneration
.
Int J Mol Sci
.
2020
;
22
(
1
):
185
.
22.
Zernant
J
,
Lee
W
,
Collison
FT
,
Fishman
GA
,
Sergeev
YV
,
Schuerch
K
, et al
.
Frequent hypomorphic alleles account for a significant fraction of ABCA4 disease and distinguish it from age-related macular degeneration
.
J Med Genet
.
2017
;
54
(
6
):
404
12
.
23.
Lee
W
,
Zernant
J
,
Nagasaki
T
,
Molday
LL
,
Su
PY
,
Fishman
GA
, et al
.
Cis-acting modifiers in the ABCA4 locus contribute to the penetrance of the major disease-causing variant in Stargardt disease
.
Hum Mol Genet
.
2021
;
30
(
14
):
1293
304
.
24.
Zernant
J
,
Schubert
C
,
Im
KM
,
Burke
T
,
Brown
CM
,
Fishman
GA
, et al
.
Analysis of the ABCA4 gene by next-generation sequencing
.
Invest Ophthalmol Vis Sci
.
2011
;
52
(
11
):
8479
87
.
25.
Braun
TA
,
Mullins
RF
,
Wagner
AH
,
Andorf
JL
,
Johnston
RM
,
Bakall
BB
, et al
.
Non-exomic and synonymous variants in ABCA4 are an important cause of Stargardt disease
.
Hum Mol Genet
.
2013
;
22
(
25
):
5136
45
.
26.
Liu
X
,
Tao
T
,
Zhao
L
,
Li
G
,
Yang
L
.
Molecular diagnosis based on comprehensive genetic testing in 800 Chinese families with non-syndromic inherited retinal dystrophies
.
Clin Exp Ophthalmol
.
2021
;
49
(
1
):
46
59
.
27.
Zhang
K
,
Garibaldi
DC
,
Kniazeva
M
,
Albini
T
,
Chiang
MF
,
Kerrigan
M
, et al
.
A novel mutation in the ABCR gene in four patients with autosomal recessive Stargardt disease
.
Am J Ophthalmol
.
1999
;
128
(
6
):
720
4
.
28.
Lin
B
,
Cai
XB
,
Zheng
ZL
,
Huang
XF
,
Liu
XL
,
Qu
J
, et al
.
Clinical and genetic analyses reveal novel pathogenic ABCA4 mutations in Stargardt disease families
.
Sci Rep
.
2016
;
6
:
35414
.
29.
Cremers
FPM
,
Lee
W
,
Collin
RWJ
,
Allikmets
R
.
Clinical spectrum, genetic complexity and therapeutic approaches for retinal disease caused by ABCA4 mutations
.
Prog Retin Eye Res
.
2020
;
79
:
100861
.
30.
Garces
F
,
Jiang
K
,
Molday
LL
,
Stöhr
H
,
Weber
BH
,
Lyons
CJ
, et al
.
Correlating the expression and functional activity of ABCA4 disease variants with the phenotype of patients with Stargardt disease
.
Invest Ophthalmol Vis Sci
.
2018
;
59
(
6
):
2305
15
.
31.
Riepe
TV
,
Khan
M
,
Roosing
S
,
Cremers
FPM
,
t’hoen
PAC
.
Benchmarking deep learning splice prediction tools using functional splice assays
.
Hum Mutat
.
2021
;
42
(
7
):
799
810
.
32.
Sangermano
R
,
Bax
NM
,
Bauwens
M
,
van den Born
LI
,
De Baere
E
,
Garanto
A
, et al
.
Photoreceptor progenitor mRNA analysis reveals exon skipping resulting from the ABCA4 c.5461-10T–>C mutation in Stargardt disease
.
Ophthalmology
.
2016
;
123
(
6
):
1375
85
.
33.
Kaltak
M
,
de Bruijn
P
,
Piccolo
D
,
Lee
SE
,
Dulla
K
,
Hoogenboezem
T
, et al
.
Antisense oligonucleotide therapy corrects splicing in the common Stargardt disease type 1-causing variant ABCA4 c.5461-10T>C
.
Mol Ther Nucleic Acids
.
2023
;
31
:
674
88
.
34.
Molday
LL
,
Wahl
D
,
Sarunic
MV
,
Molday
RS
.
Localization and functional characterization of the p.Asn965Ser (N965S) ABCA4 variant in mice reveal pathogenic mechanisms underlying Stargardt macular degeneration
.
Hum Mol Genet
.
2018
;
27
(
2
):
295
306
.
35.
Rosenberg
T
,
Klie
F
,
Garred
P
,
Schwartz
M
.
N965S is a common ABCA4 variant in Stargardt-related retinopathies in the Danish population
.
Mol Vis
.
2007
;
13
:
1962
9
.
36.
Valverde
D
,
Riveiro-Alvarez
R
,
Bernal
S
,
Jaakson
K
,
Baiget
M
,
Navarro
R
, et al
.
Microarray-based mutation analysis of the ABCA4 gene in Spanish patients with Stargardt disease: evidence of a prevalent mutated allele
.
Mol Vis
.
2006
;
12
(
1
):
902
8
.
37.
Downes
SM
,
Packham
E
,
Cranston
T
,
Clouston
P
,
Seller
A
,
Németh
AH
.
Detection rate of pathogenic mutations in ABCA4 using direct sequencing: clinical and research implications
.
Arch Ophthalmol
.
2012
;
130
(
11
):
1486
90
.
38.
Jiang
F
,
Pan
Z
,
Xu
K
,
Tian
L
,
Xie
Y
,
Zhang
X
, et al
.
Screening of ABCA4 Gene in a Chinese cohort with Stargardt disease or cone-rod dystrophy with a report on 85 novel mutations
.
Invest Ophthalmol Vis Sci
.
2016
;
57
(
1
):
145
52
.
39.
Kolawole
OU
,
Huang
A
,
Gregory-Evans
CY
,
Shunmugam
M
,
Weaver
T
,
Gregory-Evans
K
.
Molecular genetic diagnostics for inherited retinal dystrophies in the clinical setting
.
Can J Ophthalmol
.
2023
. S0008-4182(23)00256-9.
40.
Zernant
J
,
Lee
W
,
Wang
J
,
Goetz
K
,
Ullah
E
,
Nagasaki
T
, et al
.
Rare and common variants in ROM1 and PRPH2 genes trans-modify Stargardt/ABCA4 disease
.
PLoS Genet
.
2022
;
18
(
3
):
e1010129
.
41.
Ibanez
MB
4th
,
De Guimarães
TAC
,
Capasso
J
,
Bello
N
,
Levin
AV
.
Stargardt misdiagnosis: how ocular genetics helps
.
Am J Med Genet
.
2021
;
185
(
3
):
814
9
.
42.
Lee
W
,
Zernant
J
,
Su
PY
,
Nagasaki
T
,
Tsang
SH
,
Allikmets
R
.
A genotype-phenotype correlation matrix for ABCA4 disease based on long-term prognostic outcomes
.
JCI Insight
.
2022
;
7
(
2
):
e156154
.
43.
Russell
S
,
Bennett
J
,
Wellman
JA
,
Chung
DC
,
Yu
ZF
,
Tillman
A
, et al
.
Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial
.
Lancet
.
2017
;
390
(
10097
):
849
60
.
44.
Pennesi
ME
,
Weleber
RG
,
Yang
P
,
Whitebirch
C
,
Thean
B
,
Flotte
TR
, et al
.
Results at 5 years after gene therapy for RPE65-deficient retinal dystrophy
.
Hum Gene Ther
.
2018
;
29
(
12
):
1428
37
.
45.
Maguire
AM
,
Russell
S
,
Wellman
JA
,
Chung
DC
,
Yu
ZF
,
Tillman
A
, et al
.
Efficacy, safety, and durability of voretigene neparvovec-rzyl in RPE65 mutation-associated inherited retinal dystrophy: results of phase 1 and 3 trials
.
Ophthalmology
.
2019
;
126
(
9
):
1273
85
.
You do not currently have access to this content.